Drugs / Bone Marrow CD133+ Stem Cell Transplantation
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02144987 Background | Apr 2013 → Sep 2014 | Asherman syndrome | Instituto Valenciano de Infertilidad, IVI VALENCIA | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bone Marrow CD133+ Stem Cell Transplantation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02144987 ↗ |
| Known as | G-CSF | “1. Bone Marrow Stem Cell (BMSC) mobilization peripheral blood induced by granulocyte-CSF (G-CSF) 5 mcg/kg sc every 12 hours for 4 days.” NCT02144987 ↗ |
| Route | Subcutaneous | “granulocyte-CSF (G-CSF) 5 mcg/kg sc every 12 hours for 4 days” NCT02144987 ↗ |